Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(bis(2-quinolyl)ethyl)-4-m-tolylpiperazine
2. Centhaquin
1. Centhaquin
2. 57961-90-7
3. Compound-7173
4. Pmz-2010
5. Centhaquine [usan]
6. Centhaquine;pmz-2010
7. Qd4vi0j9t5
8. 2-[2-[4-(3-methylphenyl)piperazin-1-yl]ethyl]quinoline
9. Pmz2010
10. 2-(2-(4-(m-tolyl)piperazin-1-yl)ethyl)quinoline
11. Quinoline, 2-(2-(4-(3-methylphenyl)-1-piperazinyl)ethyl)-
12. Compound 7173
13. Brn 0563681
14. 2-(2-(4-(3-methylphenyl)piperazin-1-yl)ethyl)quinoline
15. 1-(beta(2-quinolyl)ethyl)-4-m-tolylpiperazine
16. 2-(2-(4-(3-methylphenyl)-1-piperazinyl)ethyl)quinoline
17. Centhaquine [inn]
18. Unii-qd4vi0j9t5
19. Zinc1105
20. Chembl4594437
21. Schembl10029638
22. Dtxsid40206680
23. Bcp31600
24. Centhaquin (centhaquine,pmz-2010)
25. Who 11138
26. Sb18795
27. Ac-35784
28. Hy-106690
29. Cs-0026357
30. 1-(bis(2-quinolyl)ethyl)-4-m-tolylpiperazine
31. 2-(2-(4-m-tolylpiperazin-1-yl)ethyl)quinoline
32. Pmz-2010; Pmz2010; Pmz 2010; Compound 7173
| Molecular Weight | 331.5 g/mol |
|---|---|
| Molecular Formula | C22H25N3 |
| XLogP3 | 4.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 331.204847810 g/mol |
| Monoisotopic Mass | 331.204847810 g/mol |
| Topological Polar Surface Area | 19.4 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 404 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Centhaquine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Centhaquine, including repackagers and relabelers. The FDA regulates Centhaquine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Centhaquine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Centhaquine supplier is an individual or a company that provides Centhaquine active pharmaceutical ingredient (API) or Centhaquine finished formulations upon request. The Centhaquine suppliers may include Centhaquine API manufacturers, exporters, distributors and traders.
Centhaquine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Centhaquine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Centhaquine GMP manufacturer or Centhaquine GMP API supplier for your needs.
A Centhaquine CoA (Certificate of Analysis) is a formal document that attests to Centhaquine's compliance with Centhaquine specifications and serves as a tool for batch-level quality control.
Centhaquine CoA mostly includes findings from lab analyses of a specific batch. For each Centhaquine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Centhaquine may be tested according to a variety of international standards, such as European Pharmacopoeia (Centhaquine EP), Centhaquine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Centhaquine USP).
LOOKING FOR A SUPPLIER?
